Share this article Share this article Stigma Grow's new licences allow for the direct sale of cannabis extracts, including their expanding lineups of shatter, live resin vape cartridges, budders, waxes and more. RED DEER, AB, Dec. 14, 2020 /CNW/ - CanadaBis Capital Inc. (TSXV:CANB) ("CanadaBis" or "the Company"), is pleased to announce that its 100% owned subsidiary, 1998643 AB LTD. ("Stigma Grow") has secured its federal licence to cultivate and process from Health Canada under the Cannabis Act, and can now sell their expanding lineup of first-to-market hydrocarbon cannabis concentrates directly from its 66,000 square foot cultivation facility in Red Deer, Alberta. CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth in the fast-emerging global cannabis market. By targeting organic growth opportunities alongside the right-fit partners, we remain focused on finding and capitalizing on chances to grow, diversify and continue to lead our industry. (CNW Group/CanadaBis Capital Inc.)